• レポートコード:QFJ1-5992 • 出版社/出版日:QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、86ページ • 納品方法:Eメール(納期:3日) • 産業分類:医薬品 |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、レタパムリンの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(1%軟膏(15グラムチューブ)、1%軟膏(30グラムチューブ))、用途別市場規模(病院、ドラッグストア)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。 ・市場概要 ・レタパムリンの市場動向 ・企業の競争状況、市場シェア ・レタパムリンの種類別市場規模と予測2016-2027(1%軟膏(15グラムチューブ)、1%軟膏(30グラムチューブ)) ・レタパムリンの用途別市場規模と予測2016-2027(病院、ドラッグストア) ・レタパムリンの北米市場規模2016-2027(アメリカ、カナダ) ・レタパムリンの欧州市場規模2016-2027(ドイツ、フランス、イギリス等) ・レタパムリンのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・レタパムリンの中南米市場規模2016-2027(メキシコ、ブラジル) ・レタパムリンの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Almirall) ・結論 |
Retapamulin is a topical antibiotic developed by GlaxoSmithKline. It is the first drug in the new class of pleuromutilin antibiotics to be approved for human use. It is marketed as an ointment under the brand names Altabax and Altargo.
Market Analysis and Insights: Global Retapamulin Market
The global Retapamulin market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retapamulin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retapamulin market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retapamulin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retapamulin market.
Global Retapamulin Scope and Market Size
Retapamulin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retapamulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
1% ointment(15-gram tubes)
1% ointment(30-gram tubes)
Segment by Application
Hospital
Drug store
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Almirall
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retapamulin Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 1% ointment(15-gram tubes)
1.2.3 1% ointment(30-gram tubes)
1.3 Market by Application
1.3.1 Global Retapamulin Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Retapamulin Market Perspective (2016-2027)
2.2 Retapamulin Growth Trends by Regions
2.2.1 Retapamulin Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Retapamulin Historic Market Share by Regions (2016-2021)
2.2.3 Retapamulin Forecasted Market Size by Regions (2022-2027)
2.3 Retapamulin Industry Dynamic
2.3.1 Retapamulin Market Trends
2.3.2 Retapamulin Market Drivers
2.3.3 Retapamulin Market Challenges
2.3.4 Retapamulin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Retapamulin Players by Revenue
3.1.1 Global Top Retapamulin Players by Revenue (2016-2021)
3.1.2 Global Retapamulin Revenue Market Share by Players (2016-2021)
3.2 Global Retapamulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Retapamulin Revenue
3.4 Global Retapamulin Market Concentration Ratio
3.4.1 Global Retapamulin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retapamulin Revenue in 2020
3.5 Retapamulin Key Players Head office and Area Served
3.6 Key Players Retapamulin Product Solution and Service
3.7 Date of Enter into Retapamulin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Retapamulin Breakdown Data by Type
4.1 Global Retapamulin Historic Market Size by Type (2016-2021)
4.2 Global Retapamulin Forecasted Market Size by Type (2022-2027)
5 Retapamulin Breakdown Data by Application
5.1 Global Retapamulin Historic Market Size by Application (2016-2021)
5.2 Global Retapamulin Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Retapamulin Market Size (2016-2027)
6.2 North America Retapamulin Market Size by Type
6.2.1 North America Retapamulin Market Size by Type (2016-2021)
6.2.2 North America Retapamulin Market Size by Type (2022-2027)
6.2.3 North America Retapamulin Market Size by Type (2016-2027)
6.3 North America Retapamulin Market Size by Application
6.3.1 North America Retapamulin Market Size by Application (2016-2021)
6.3.2 North America Retapamulin Market Size by Application (2022-2027)
6.3.3 North America Retapamulin Market Size by Application (2016-2027)
6.4 North America Retapamulin Market Size by Country
6.4.1 North America Retapamulin Market Size by Country (2016-2021)
6.4.2 North America Retapamulin Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Retapamulin Market Size (2016-2027)
7.2 Europe Retapamulin Market Size by Type
7.2.1 Europe Retapamulin Market Size by Type (2016-2021)
7.2.2 Europe Retapamulin Market Size by Type (2022-2027)
7.2.3 Europe Retapamulin Market Size by Type (2016-2027)
7.3 Europe Retapamulin Market Size by Application
7.3.1 Europe Retapamulin Market Size by Application (2016-2021)
7.3.2 Europe Retapamulin Market Size by Application (2022-2027)
7.3.3 Europe Retapamulin Market Size by Application (2016-2027)
7.4 Europe Retapamulin Market Size by Country
7.4.1 Europe Retapamulin Market Size by Country (2016-2021)
7.4.2 Europe Retapamulin Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Retapamulin Market Size (2016-2027)
8.2 Asia-Pacific Retapamulin Market Size by Type
8.2.1 Asia-Pacific Retapamulin Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Retapamulin Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Retapamulin Market Size by Type (2016-2027)
8.3 Asia-Pacific Retapamulin Market Size by Application
8.3.1 Asia-Pacific Retapamulin Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Retapamulin Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Retapamulin Market Size by Application (2016-2027)
8.4 Asia-Pacific Retapamulin Market Size by Region
8.4.1 Asia-Pacific Retapamulin Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Retapamulin Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Retapamulin Market Size (2016-2027)
9.2 Latin America Retapamulin Market Size by Type
9.2.1 Latin America Retapamulin Market Size by Type (2016-2021)
9.2.2 Latin America Retapamulin Market Size by Type (2022-2027)
9.2.3 Latin America Retapamulin Market Size by Type (2016-2027)
9.3 Latin America Retapamulin Market Size by Application
9.3.1 Latin America Retapamulin Market Size by Application (2016-2021)
9.3.2 Latin America Retapamulin Market Size by Application (2022-2027)
9.3.3 Latin America Retapamulin Market Size by Application (2016-2027)
9.4 Latin America Retapamulin Market Size by Country
9.4.1 Latin America Retapamulin Market Size by Country (2016-2021)
9.4.2 Latin America Retapamulin Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Retapamulin Market Size (2016-2027)
10.2 Middle East & Africa Retapamulin Market Size by Type
10.2.1 Middle East & Africa Retapamulin Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Retapamulin Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Retapamulin Market Size by Type (2016-2027)
10.3 Middle East & Africa Retapamulin Market Size by Application
10.3.1 Middle East & Africa Retapamulin Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Retapamulin Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Retapamulin Market Size by Application (2016-2027)
10.4 Middle East & Africa Retapamulin Market Size by Country
10.4.1 Middle East & Africa Retapamulin Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Retapamulin Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Almirall
11.1.1 Almirall Company Details
11.1.2 Almirall Business Overview
11.1.3 Almirall Retapamulin Introduction
11.1.4 Almirall Revenue in Retapamulin Business (2016-2021)
11.1.5 Almirall Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Retapamulin Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 1% ointment(15-gram tubes)
Table 3. Key Players of 1% ointment(30-gram tubes)
Table 4. Global Retapamulin Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Retapamulin Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Retapamulin Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Retapamulin Market Share by Regions (2016-2021)
Table 8. Global Retapamulin Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Retapamulin Market Share by Regions (2022-2027)
Table 10. Retapamulin Market Trends
Table 11. Retapamulin Market Drivers
Table 12. Retapamulin Market Challenges
Table 13. Retapamulin Market Restraints
Table 14. Global Retapamulin Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Retapamulin Market Share by Players (2016-2021)
Table 16. Global Top Retapamulin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retapamulin as of 2020)
Table 17. Ranking of Global Top Retapamulin Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Retapamulin Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Retapamulin Product Solution and Service
Table 21. Date of Enter into Retapamulin Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Retapamulin Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Retapamulin Revenue Market Share by Type (2016-2021)
Table 25. Global Retapamulin Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Retapamulin Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Retapamulin Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Retapamulin Revenue Market Share by Application (2016-2021)
Table 29. Global Retapamulin Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Retapamulin Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Retapamulin Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Retapamulin Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Retapamulin Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Retapamulin Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Retapamulin Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Retapamulin Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Retapamulin Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Retapamulin Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Retapamulin Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Retapamulin Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Retapamulin Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Retapamulin Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Retapamulin Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Retapamulin Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Retapamulin Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Retapamulin Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Retapamulin Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Retapamulin Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Retapamulin Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Retapamulin Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Retapamulin Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Retapamulin Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Retapamulin Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Retapamulin Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Retapamulin Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Retapamulin Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Retapamulin Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Retapamulin Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Retapamulin Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Retapamulin Market Size by Country (2022-2027) & (US$ Million)
Table 61. Almirall Company Details
Table 62. Almirall Business Overview
Table 63. Almirall Retapamulin Product
Table 64. Almirall Revenue in Retapamulin Business (2016-2021) & (US$ Million)
Table 65. Almirall Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retapamulin Market Share by Type: 2020 VS 2027
Figure 2. 1% ointment(15-gram tubes) Features
Figure 3. 1% ointment(30-gram tubes) Features
Figure 4. Global Retapamulin Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Drug store Case Studies
Figure 7. Retapamulin Report Years Considered
Figure 8. Global Retapamulin Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Retapamulin Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Retapamulin Market Share by Regions: 2020 VS 2027
Figure 11. Global Retapamulin Market Share by Regions (2022-2027)
Figure 12. Global Retapamulin Market Share by Players in 2020
Figure 13. Global Top Retapamulin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retapamulin as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Retapamulin Revenue in 2020
Figure 15. Global Retapamulin Revenue Market Share by Type (2016-2021)
Figure 16. Global Retapamulin Revenue Market Share by Type (2022-2027)
Figure 17. North America Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Retapamulin Market Share by Type (2016-2027)
Figure 19. North America Retapamulin Market Share by Application (2016-2027)
Figure 20. North America Retapamulin Market Share by Country (2016-2027)
Figure 21. United States Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Retapamulin Market Share by Type (2016-2027)
Figure 25. Europe Retapamulin Market Share by Application (2016-2027)
Figure 26. Europe Retapamulin Market Share by Country (2016-2027)
Figure 27. Germany Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Retapamulin Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Retapamulin Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Retapamulin Market Share by Region (2016-2027)
Figure 37. China Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Retapamulin Market Share by Type (2016-2027)
Figure 45. Latin America Retapamulin Market Share by Application (2016-2027)
Figure 46. Latin America Retapamulin Market Share by Country (2016-2027)
Figure 47. Mexico Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Retapamulin Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Retapamulin Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Retapamulin Market Share by Country (2016-2027)
Figure 53. Turkey Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Retapamulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Almirall Revenue Growth Rate in Retapamulin Business (2016-2021)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed